European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Market report

Cardiovascular drug tenders in Portugal — market report, February 2026

Cardiovascular drug tenders in Portugal in February 2026: 272 tenders published (-11% month on month, +11% year on year), and 177 contracts awarded (-55% month on month, -45% year on year), worth €281,992 (awarded value). Buyers with the most tenders: Unidade Local de Saúde de Santa Maria, E. P. E. (24), Unidade Local de Saúde de Gaia/Espinho, E. P. E. (20) and Instituto Português de Oncologia do Porto Francisco Gentil, E. P. E. (17); most contracts won: Hikma Farmacêutica (Portugal) Sa. (16), Grindeks Kalceks Portugal Sociedade Unipessoal Lda (13) and Labesfal-Lab. Almiro, Sa. (12). On average 6.6 bids per contract; 6% of contracts had a single bid. Report made on 27 October 2026.

Tenders published
272
Contracts awarded
177
Contract value awarded
€281,992
Bids per contract
6.6
Tenders published per month
0100200300400Feb 25: 246Feb 25: 246Feb 25Mar 25: 247Mar 25: 247Mar 25Apr 25: 194Apr 25: 194Apr 25May 25: 84May 25: 84May 25Jun 25: 21Jun 25: 21Jun 25Jul 25: 177Jul 25: 177Jul 25Aug 25: 155Aug 25: 155Aug 25Sep 25: 49Sep 25: 49Sep 25Oct 25: 105Oct 25: 105Oct 25Nov 25: 111Nov 25: 111Nov 25Dec 25: 43Dec 25: 43Dec 25Jan 26: 306Jan 26: 306Jan 26Feb 26: 272Feb 26: 272272Feb 26
Contracts awarded per month
0100200300400Feb 25: 320Feb 25: 320Feb 25Mar 25: 206Mar 25: 206Mar 25Apr 25: 175Apr 25: 175Apr 25May 25: 53May 25: 53May 25Jun 25: 37Jun 25: 37Jun 25Jul 25: 203Jul 25: 203Jul 25Aug 25: 101Aug 25: 101Aug 25Sep 25: 85Sep 25: 85Sep 25Oct 25: 70Oct 25: 70Oct 25Nov 25: 126Nov 25: 126Nov 25Dec 25: 68Dec 25: 68Dec 25Jan 26: 390Jan 26: 390Jan 26Feb 26: 177Feb 26: 177177Feb 26

The highlighted bar is February 2026. Hover a bar for its figure; the table below has every value.

FigureFebruary 2026January 2026ChangeFebruary 2025Change
Tenders published272306-11%246+11%
Estimated value—————
Buyers2427-11%29-17%
Contracts awarded177390-55%320-45%
Contract value (awarded)€281,992——€669,597-58%
Winners36360%49-27%
Bids per contract6.67.0—10.5—
Single-bid contracts6%0%—1%—

Buyers with the most tenders

Companies with the most contracts

Procedures

  • not stated 272

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Cardiovascular and anticoagulant drugs

Questions and answers

How many cardiovascular drug tenders were published in Portugal in February 2026?
272 (by 24 buyers); for comparison, January 2026: 306, February 2025: 246.
Who won the most cardiovascular drug tenders in Portugal in February 2026?
By number of contracts: Hikma Farmacêutica (Portugal) Sa. (16), Grindeks Kalceks Portugal Sociedade Unipessoal Lda (13), Labesfal-Lab. Almiro, Sa. (12), Fresenius Kabi Pharma Portugal (11) and Orionfin Unipessoal Lda. (11); 36 companies won contracts in all.
Which buyers published the most cardiovascular drug tenders in February 2026?
Unidade Local de Saúde de Santa Maria, E. P. E. (24), Unidade Local de Saúde de Gaia/Espinho, E. P. E. (20), Instituto Português de Oncologia do Porto Francisco Gentil, E. P. E. (17), Unidade Local de Saúde de Entre O Douro e Vouga, E.P.E (16) and Unidade Local de Saúde da Região de Aveiro, E. P. E. (14).
How competitive were cardiovascular drug tenders in Portugal in February 2026?
On average 6.6 bids per contract (17 contracts with a known number of bids); 6% of contracts had a single bid.
What were the contracts worth in February 2026?
€281,992 (awarded value, 177 contracts); median about €1,200.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.